Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.

Toxicology letters 20160226

Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1).

Toxicological sciences : an official journal of the Society of Toxicology 20160101

Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.

Chemical research in toxicology 20151116

Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.

Toxicological sciences : an official journal of the Society of Toxicology 20151101

Nitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators.

Toxicology letters 20150615

Myeloperoxidase deficiency attenuates nitrogen mustard-induced skin injuries.

Toxicology 20140605

Cross-linking of thioredoxin reductase by the sulfur mustard analogue mechlorethamine (methylbis(2-chloroethyl)amine) in human lung epithelial cells and rat lung: selective inhibition of disulfide reduction but not redox cycling.

Chemical research in toxicology 20140121

Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker.

European journal of medicinal chemistry 20140101

Modified immunoslotblot assay to detect hemi and sulfur mustard DNA adducts.

Chemico-biological interactions 20131205

The generation of 4-hydroxynonenal, an electrophilic lipid peroxidation end product, in rabbit cornea organ cultures treated with UVB light and nitrogen mustard.

Toxicology and applied pharmacology 20131015

Absence of a p53 allele delays nitrogen mustard-induced early apoptosis and inflammation of murine skin.

Toxicology 20130915

Ebselen reduces the toxicity of mechlorethamine in A-431 cells via inhibition of apoptosis.

Journal of biochemical and molecular toxicology 20130601

Attenuation of acute nitrogen mustard-induced lung injury, inflammation and fibrogenesis by a nitric oxide synthase inhibitor.

Toxicology and applied pharmacology 20121215

Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.

Leukemia & lymphoma 20121201

Synthesis and cytotoxicity studies of bifunctional hybrids of nitrogen mustards with potential enzymes inhibitors based on melamine framework.

Journal of enzyme inhibition and medicinal chemistry 20121001

Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.

Toxicology and applied pharmacology 20121001

Synthesis and antitumor activity of formononetin nitrogen mustard derivatives.

European journal of medicinal chemistry 20120801

The mechanism of guanine alkylation by nitrogen mustards: a computational study.

The Journal of organic chemistry 20120720

Protective effects of melatonin and S-methylisothiourea on mechlorethamine induced nephrotoxicity.

The Journal of surgical research 20120601

Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents.

Biochemical pharmacology 20120501

Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.

Environmental and molecular mutagenesis 20120501

Characterization and study of piperazinium salts, degradation products of nitrogen mustards by nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry.

Journal of chromatography. A 20120302

Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis.

The British journal of dermatology 20120301

Common stem: -mustine.

Prescrire international 20120301

Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

International journal of radiation oncology, biology, physics 20120201

DNA interstrand cross-linking agents and their chemotherapeutic potential.

Current medicinal chemistry 20120101

New thymine-based derivative of nitrogen mustards.

Nucleosides, nucleotides & nucleic acids 20120101

Mechlorethamine (NTG) effects on the erythrocytic and leukocytic blood parameters during experimentally induced pleuritis in rats.

Pharmacological reports : PR 20120101

Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.

Journal of the American Chemical Society 20111207

Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

Insight into hydrolytic reaction of N-acetylated L-histidylglycine dipeptide with novel mechlorethamine platinum(II) complex. NMR and DFT study of the hydrolytic reaction.

Dalton transactions (Cambridge, England : 2003) 20110928

Array of Love-wave sensors based on quartz/Novolac to detect CWA simulants.

Talanta 20110915

High-throughput sample preparation and simultaneous column regeneration liquid chromatography-tandem mass spectrometry method for determination of nitrogen mustard metabolites in human urine.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110815

Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells.

Journal of proteome research 20110603

Determination of nitrogen mustard hydrolysis products in rat urine samples using GC-MS.

Journal of chromatographic science 20110501

The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.

Archives of dermatology 20110501

First use of intravenous chemotherapy cancer treatment: rectifying the record.

Journal of the American College of Surgeons 20110301

Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries.

Biomaterials 20110201

Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard.

Toxicology and applied pharmacology 20110101

Estimation of the action of three different mechlorethamine doses on biochemical parameters during experimentally induced pleuritis in rats.

Pharmacological reports : PR 20110101

HPLC-UV, MALDI-TOF-MS and ESI-MS/MS analysis of the mechlorethamine DNA crosslink at a cytosine-cytosine mismatch pair.

PloS one 20110101

Nitrogen mustard hydrochloride.

Report on carcinogens : carcinogen profiles 20110101

Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.

Journal of toxicology and environmental health. Part A 20110101

The effect of Nitrogen Mustard on the enzymatic antioxidant defense of rat brain tissue and the therapeutic value of proanthocyanidin.

Turkish neurosurgery 20110101

The effect of sulfur mustard and nitrogen mustard on corneal collagen degradation induced by the enzyme collagenase.

Cutaneous and ocular toxicology 20101201

Accelerated aging of intervertebral discs in a mouse model of progeria.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20101201

Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.

Veterinary and comparative oncology 20101201

Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.

Journal of drugs in dermatology : JDD 20101101

Specific nail alterations in cutaneous T-cell lymphoma: successful treatment with topical mechlorethamine.

Archives of dermatology 20101101

Nitrogen and sulphur mustard induced histopathological observations in mouse visceral organs.

Journal of environmental biology 20101101

Hodgkin's lymphoma: Richter's transformation of chronic lymphocytic leukemia involving the liver.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

Mutagenesis of nucleophilic residues near the orthosteric binding pocket of M1 and M2 muscarinic receptors: effect on the binding of nitrogen mustard analogs of acetylcholine and McN-A-343.

Molecular pharmacology 20101001

Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.

Journal of pediatric hematology/oncology 20101001

Doxycycline hydrogels as a potential therapy for ocular vesicant injury.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001

Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.

Anticancer research 20101001

Comparative toxic effect of nitrogen mustards (HN-1, HN-2, and HN-3) and sulfur mustard on hematological and biochemical variables and their protection by DRDE-07 and its analogues.

International journal of toxicology 20100701

Innovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard.

Dermatologic clinics 20100701

The influence of chromatin structure on DNA damage induced by nitrogen mustard and cisplatin analogues.

Chemical biology & drug design 20100601

Kin3 protein, a NIMA-related kinase of Saccharomyces cerevisiae, is involved in DNA adduct damage response.

Cell cycle (Georgetown, Tex.) 20100601

Lipomatosis: an unusual side-effect of cytotoxic chemotherapy?

Acta dermato-venereologica 20100501

Application of high performance liquid chromatography coupled to on-line solid-phase extraction-nuclear magnetic resonance spectroscopy for the analysis of degradation products of V-class nerve agents and nitrogen mustard.

Journal of chromatography. A 20100423

Aziridinium ion ring formation from nitrogen mustards: mechanistic insights from ab initio dynamics.

The journal of physical chemistry. A 20100408

Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.

Leukemia & lymphoma 20100401

The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.

European journal of haematology 20100301

Immune thrombocytopenic purpura at the diagnosis of Hodgkin disease.

Acta clinica Belgica 20100101

Hypopigmented macules and patches on the extremities of a teenager.

Pediatric dermatology 20100101

Long-term follow-up of survival in Hodgkin's lymphoma.

The New England journal of medicine 20091210

Pragmatic classification of superficial neoplastic colorectal lesions.

Gastrointestinal endoscopy 20091201

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

International journal of radiation oncology, biology, physics 20091201

Cutaneous T-cell lymphoma: a review of current therapies and the future therapeutic implications of chemokine biology.

Journal of drugs in dermatology : JDD 20091201

The effect of nitrogen mustard on the rat brain and the therapeutic value of proanthocyanidin.

Turkish neurosurgery 20091001

Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.

Leukemia & lymphoma 20091001

Topical chlormethine hydrochloride causing bullous reaction.

Clinical toxicology (Philadelphia, Pa.) 20090901

DRDE-07 and its analogues as promising cytoprotectants to nitrogen mustard (HN-2)--an alkylating anticancer and chemical warfare agent.

Toxicology letters 20090810

Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine.

Archiv der Pharmazie 20090801

[Nasopharyngeal carcinoma in sub-Saharan Africa: a tribute to Mr. Peter Clifford].

Ai zheng = Aizheng = Chinese journal of cancer 20090801

Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.

Annals of hematology 20090701

Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.

Leukemia & lymphoma 20090701

Development of spray deposition/MALDI-TOFMS and its application to the rapid screening of hydrolysis products derived from nitrogen mustards.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20090701

Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.

The Journal of clinical endocrinology and metabolism 20090601

DNA repair modulates the vulnerability of the developing brain to alkylating agents.

DNA repair 20090301

Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.

Veterinary and comparative oncology 20090301

A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants.

Toxicology letters 20090225

Generation of DNA interstrand cross-links by post-synthetic reductive amination.

Organic letters 20090205

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.

British journal of haematology 20090201

Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.

Anticancer research 20090201

[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].

Journal de radiologie 20090101

Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.

Journal of veterinary internal medicine 20090101

Influence of cyclophosphamide and its metabolic products on the activity of peritoneal macrophages in mice.

Pharmacological reports : PR 20090101

Asparaginase and MOPP treatment of dogs with lymphoma.

Journal of veterinary internal medicine 20090101

[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].

Voprosy onkologii 20090101

Standard therapy of advanced Hodgkin lymphoma.

Hematology. American Society of Hematology. Education Program 20090101

Breast cancer after treatment of Hodgkin's lymphoma: general review.

International journal of radiation oncology, biology, physics 20081201

Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.

Journal of pediatric hematology/oncology 20081201

Comparison of toxicity of selected mustard agents by percutaneous and subcutaneous routes.

Indian journal of experimental biology 20081201

Prognostic factors in children with Hodgkin disease.

Pediatric blood & cancer 20081101

Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.

Journal of the American Academy of Dermatology 20081001

Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.

International journal of pharmaceutics 20081001

Treatment of Hodgkin lymphoma: the past, present, and future.

Nature clinical practice. Oncology 20080901

[Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].

Actas dermo-sifiliograficas 20080901

Ovarian function preservation in patients under chemotherapy treatment.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080901

[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080801

Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.

Journal of pediatric hematology/oncology 20080701

Single-molecule detection of nitrogen mustards by covalent reaction within a protein nanopore.

Journal of the American Chemical Society 20080528

Modifications and insights into a method for the analysis of the nitrogen mustard mechlorethamine by high-performance liquid chromatography.

Analytica chimica acta 20080526

Results of treatment of 112 cases of primary CNS lymphoma.

Japanese journal of clinical oncology 20080501

[Phyllanthus urinaria extract promotes N-cadherin expression in nitrogen mustard-disrupted testicular tissues in vivo].

Zhonghua nan ke xue = National journal of andrology 20080501

A 4-month-old boy with diaper dermatitis. Langerhans cell histiocytosis.

Pediatric annals 20080401

Systemic chemotherapy for cancer: from weapon to treatment.

The Lancet. Oncology 20080301

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

The New England journal of medicine 20080214

Treatment-related risk factors for premature menopause following Hodgkin lymphoma.

Blood 20080101

Development of a liquid chromatography-multiple reaction monitoring procedure for concurrent verification of exposure to different forms of mustard agents.

Journal of analytical toxicology 20080101

Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.

Dermatology (Basel, Switzerland) 20080101

[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].

Voprosy onkologii 20080101

Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells.

Cutaneous and ocular toxicology 20080101

The new analogues of nitrogen mustard with one, two or three 2-chloroethylamino fragments. Reactions with nucleophiles.

Acta poloniae pharmaceutica 20080101

[Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].

Voprosy onkologii 20080101

Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.

Human reproduction (Oxford, England) 20071201

[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

Ai zheng = Aizheng = Chinese journal of cancer 20071201

[Chlormethine (Caryolysine), carmustine (Bicnu)].

Annales de dermatologie et de venereologie 20071201

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

The New England journal of medicine 20071108

Tissue injury by hot fluid containing nitrogen mustard.

Burns : journal of the International Society for Burn Injuries 20071101

Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.

The Journal of clinical endocrinology and metabolism 20071001

Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).

The British journal of radiology 20071001

Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard.

Toxicology letters 20070910

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats.

Research in veterinary science 20070801

Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20070801

Mycosis fungoides.

Dermatology nursing 20070801

Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.

Leukemia & lymphoma 20070601

Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.

Cancer research 20070501

Ebselen protects brain, skin, lung and blood cells from mechlorethamine toxicity.

Toxicology and industrial health 20070501

[Our experiences in treating patients with Hodgkin disease in the last decade].

Orvosi hetilap 20070415

Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor kappaB responses and cell death are altered by caffeic acid phenethyl ester: a potential role for antioxidant/electrophilic response-element signaling.

The Journal of pharmacology and experimental therapeutics 20070401

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

Hematology (Amsterdam, Netherlands) 20070401

Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.

Cancer science 20070301

Hodgkin lymphoma among patients infected with HIV in post-HAART era.

Clinical lymphoma & myeloma 20070301

Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.

Experimental cell research 20070215

Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.

International journal of clinical oncology 20070201

Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.

Oncology (Williston Park, N.Y.) 20070201

Molecular mechanism of nitrogen mustard induced leukocyte(s) chemotaxis.

Medical hypotheses 20070101

Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.

International journal of radiation oncology, biology, physics 20070101

Cytoskeleton vimentin disruption of mouse sertoli cells injured by nitrogen mustard in vitro.

Journal of andrology 20070101

Topical nitrogen mustard for the treatment of granulomatous slack skin.

American journal of clinical dermatology 20070101

Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.

Anticancer research 20070101

[Evolution in 18F-FDG-PET of a case of Hodgkin disease, nodular sclerosis variety, after treatment and autotrasplant].

Revista espanola de medicina nuclear 20070101

Ocular effects of exposure to industrial chemicals: clinical management and proteomic approaches to damage assessment.

Cutaneous and ocular toxicology 20070101

Down-regulation of HER-2 expression in human breast cancer cell HBC-4 and ZR75-1 by nitrogen-mustard-N-oxide.

The Kobe journal of medical sciences 20070101

Alkylation activity and molecular properties of two antineoplastic agents that utilise indometacin and a conjugate of aspirin with 2-aminonicotinic acid to transport nitrogen mustard groups.

Drugs in R&D 20070101

Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061220

Eruptive cherry angiomas associated with vitiligo: provoked by topical nitrogen mustard?

The Journal of dermatology 20061201

Treatment of cutaneous T-cell lymphoma/mycosis fungoides.

Dermatology nursing 20061201

Drosophila homologs of FANCD2 and FANCL function in DNA repair.

DNA repair 20061108

Rational design, synthesis and in vitro evaluation of three new alkylating steroidal esters.

Medicinal chemistry (Shariqah (United Arab Emirates)) 20061101

Genotoxicants target distinct molecular networks in neonatal neurons.

Environmental health perspectives 20061101

Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.

Annals of hematology 20061001

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061001

Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis.

Apoptosis : an international journal on programmed cell death 20060901

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Ai zheng = Aizheng = Chinese journal of cancer 20060801

Determination of nitrogen mustard hydrolysis products, ethanolamines by gas chromatography-mass spectrometry after tert-butyldimethylsilyl derivatization.

Journal of chromatography. A 20060728

Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060701

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Blood 20060615

Topical mechlorethamine and clobetasol in multifocal primary cutaneous marginal zone-B cell lymphoma.

The British journal of dermatology 20060601

Hodgkin's lymphoma in adolescents.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.

Journal of pediatric hematology/oncology 20060601

New mustard-linked 2-aryl-bis-benzimidazoles with anti-proliferative activity.

Organic & biomolecular chemistry 20060407

[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].

Ai zheng = Aizheng = Chinese journal of cancer 20060401

[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].

Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301

MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research 20060115

Screening of nitrogen mustards and their degradation products in water and decontamination solution by liquid chromatography-mass spectrometry.

Journal of chromatography. A 20060113

Bullous reaction to topical methchlorethamine in mycosis fungoides.

Journal of drugs in dermatology : JDD 20060101

Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism.

Clinical chemistry and laboratory medicine 20060101

[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].

Terapevticheskii arkhiv 20060101

Mycosis fungoides with tinea pseudoimbricata owing to Trichophyton rubrum infection.

Journal of cutaneous medicine and surgery 20060101

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.

International journal of radiation oncology, biology, physics 20051201

Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.

American journal of clinical oncology 20051201

New treatment options have changed the survival of patients with follicular lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120

Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

International journal of radiation oncology, biology, physics 20051115

Design and synthesis of a DNA-crosslinking azinomycin analogue.

Organic & biomolecular chemistry 20051007

S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents.

Leukemia research 20051001

Analysis of the nitrogen mustard mechlorethamine in topical pharmaceutical preparations by high-performance liquid chromatography.

Journal of chromatography. A 20050902

Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.

American journal of hematology 20050901

Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.

Archives of dermatology 20050901

Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.

Clinical lymphoma & myeloma 20050901

[Observation on the 78th meeting of the Japanese Society for Hansen's Disease].

Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20050901

[Local treatments of cutaneous T-cell lymphomas].

Annales de dermatologie et de venereologie 20050901

Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.

Annals of hematology 20050701

Aquatic toxicity of nitrogen mustard to Ceriodaphina dubia, Daphnia magna, and Pimephales promelas.

Ecotoxicology and environmental safety 20050601

Secondary transitional cell carcinoma and nitrogen mustard treatment.

Urology 20050601

On-matrix derivatisation-extraction of precursors of nitrogen- and sulfur-mustards for verification of chemical weapons convention.

Journal of chromatography. A 20050527

Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.

Journal of cellular biochemistry 20050515

Cytokinetics and mechanism of action of AKO4: a novel nitrogen mustard targeted to bcr-abl.

Leukemia research 20050501

Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids.

Investigative ophthalmology & visual science 20050501

Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.

Cancer genetics and cytogenetics 20050501

Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.

European journal of cancer (Oxford, England : 1990) 20050501

Nitrogen mustard- and half-mustard-induced damage in Escherichia coli requires different DNA repair pathways.

Mutation research 20050404

Footprinting the 'essential regulatory region' of the retinoblastoma gene promoter in intact human cells.

The international journal of biochemistry & cell biology 20050301

Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20050201

[Primary treatment of advanced Hodgkin's disease].

Orvosi hetilap 20050130

A chick model for the mechanisms of mustard gas neurobehavioral teratogenicity.

Neurotoxicology and teratology 20050101

Evaluation of protective ointments used against dermal effects of nitrogen mustard, a vesicant warfare agent.

Military medicine 20050101

Targeting and regulation of the HER-2/neu oncogene promoter with bis-peptide nucleic acids.

Oligonucleotides 20050101

Gas chromatography-mass spectrometry analysis of trifluoroacetyl derivatives of precursors of nitrogen and sulfur mustards for verification of chemical weapons convention.

Journal of chromatography. A 20041203

Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?

International journal of dermatology 20041201

Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1.

Human molecular genetics 20041015

Flanking sequences modulate diepoxide and mustard cross-linking efficiencies at the 5'-GNC site.

Chemical research in toxicology 20040801

Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.

Pediatric blood & cancer 20040701

Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.

International journal of radiation oncology, biology, physics 20040701

Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.

Chemical research in toxicology 20040701

Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.

Haematologica 20040601

Genomic and phylogenetic footprinting at the epsilon-globin silencer region in intact human cells.

Biochimica et biophysica acta 20040525

Chloroalkyl piperazine and nitrogen mustard porphyrins: synthesis and anticancer activity.

Bioorganic & medicinal chemistry 20040501

A large-scale screen for mutagen-sensitive loci in Drosophila.

Genetics 20040501

Dual purpose: some cancer therapies used to treat autoimmune diseases.

Journal of the National Cancer Institute 20040421

Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.

Pediatric blood & cancer 20040301

Pediatric Hodgkin's disease.

The Journal of the Kentucky Medical Association 20040301

Sticky DNA formation in vivo alters the plasmid dimer/monomer ratio.

The Journal of biological chemistry 20040220

Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.

Annals of oncology : official journal of the European Society for Medical Oncology 20040201

Therapeutic options in patients with lymphoma and severe liver dysfunction.

Mayo Clinic proceedings 20040201

What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?

Current hematology reports 20040101

Secondary axillary node carcinoma following treatment of Hodgkin's disease.

The breast journal 20040101

Quantitation of biomarkers of exposure to nitrogen mustards in urine from rats dosed with nitrogen mustards and from an unexposed human population.

Journal of analytical toxicology 20040101

Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.

Acta haematologica 20040101

[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].

Przeglad lekarski 20040101

Nitrogen mustard hydrochloride.

Report on carcinogens : carcinogen profiles 20040101

Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.

International journal of radiation oncology, biology, physics 20031201

Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.

Bone marrow transplantation 20031201

The treatment of adults with medulloblastoma: a prospective study.

International journal of radiation oncology, biology, physics 20031101

[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20031001

Old wine in new bottles: reviving old therapies for alopecia areata using rodent models.

The journal of investigative dermatology. Symposium proceedings 20031001

[Hematologic tumors].

Gan to kagaku ryoho. Cancer & chemotherapy 20031001

Radiotherapy for advanced Hodgkin's disease.

The New England journal of medicine 20030918

Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study.

Journal of the American Academy of Dermatology 20030801

The protective and therapeutic effects of zinc chloride and desferrioxamine on skin exposed to nitrogen mustard.

Military medicine 20030801

Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?

Journal of the National Cancer Institute 20030702

Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.

International journal of radiation oncology, biology, physics 20030701

Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard.

Investigative ophthalmology & visual science 20030701

Revascularization for acute coronary occlusion in a young woman following radiation.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20030701

High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

Involved-field radiotherapy for advanced Hodgkin's lymphoma.

The New England journal of medicine 20030612

[Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].

La Revue de medecine interne 20030401

Differential diagnosis of Fanconi anemia by nitrogen mustard and diepoxybutane.

Annals of hematology 20030401

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Blood 20030301

Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes.

The Journal of investigative dermatology 20030301

Advanced Hodgkin's disease: ABVD is better, yet is not good enough!

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.

Archives of dermatology 20030201

Quantitative determination of the hydrolysis products of nitrogen mustards in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry.

Journal of analytical toxicology 20030101

Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug.

Bioconjugate chemistry 20030101

Topical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalp.

The Journal of dermatological treatment 20030101

Impaired healing of nitrogen mustard wounds in CXCR2 null mice.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 20030101

Cutaneous granulomas as the first manifestation of Hodgkin's disease.

European journal of dermatology : EJD 20030101

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.

Cancer 20021215

Pathways of reductive fragmentation of heterocyclic nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine.

Radiation research 20021201

Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology 20021201

Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology 20021201

[Psoriasis of the scalp].

Annales de dermatologie et de venereologie 20021201

Evaluation of a 1-h exposure time to mechlorethamine in patients undergoing topical treatment.

The British journal of dermatology 20021101

Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).

Annals of oncology : official journal of the European Society for Medical Oncology 20021001

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

Blood 20020915

The ability to engage enterocyte apoptosis does not predict long-term crypt survival in p53 and Msh2 deficient mice.

Oncogene 20020829

Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.

British journal of haematology 20020701

Pulmonary toxicity secondary to procarbazine.

American journal of clinical oncology 20020401

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.

Cancer 20020315

Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.

Archives of toxicology 20020301

Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity.

Archives of toxicology 20020301

Subdiaphragmatic Hodgkin's disease: the University of Florida experience.

International journal of radiation oncology, biology, physics 20020101

Sulfur mustard-stimulated protease: a target for antivesicant drugs.

Journal of applied toxicology : JAT 20020101

Treatment of cutaneous T cell lymphoma: current status and future directions.

American journal of clinical dermatology 20020101

ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology 20020101

From poison gas to wonder drug.

American heritage of invention & technology 20020101

[Cured from Hodgkin's disease].

Bulletin du cancer 20020101

MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).

Journal of veterinary internal medicine 20020101

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.

Cancer journal (Sudbury, Mass.) 20020101

[Z-form of intraphage DNA].

Molekuliarnaia genetika, mikrobiologiia i virusologiia 20020101

Nitrogen mustard hydrochloride.

Report on carcinogens : carcinogen profiles 20020101

Chromatin structure at the 3'-boundary of the human beta-globin locus control region hypersensitive site-2.

The international journal of biochemistry & cell biology 20011201

The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.

Carcinogenesis 20011201

Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.

Clinical lymphoma 20011201

Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.

Annals of hematology 20011101

ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.

Annals of oncology : official journal of the European Society for Medical Oncology 20010901

Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.

Cancer 20010801

Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.

Journal of neuro-oncology 20010801

Follicular mycosis fungoides: a case report and review of the literature.

Journal of cutaneous pathology 20010701

Genetic damage by bifunctional agents in repair-active pre-meiotic stages of Drosophila males.

Mutation research 20010701

The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.

Leukemia & lymphoma 20010701

Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity.

Toxicology 20010621

Chlorophyllin protects cells from the cytostatic and cytotoxic effects of quinacrine mustard but not of nitrogen mustard.

International journal of oncology 20010401

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital.

International journal of radiation oncology, biology, physics 20010401

[The chemotherapeutic treatment of advanced Hodgkin's disease].

Harefuah 20010401

Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010315

Inhibition by leukocyte depletion of neointima formation after balloon angioplasty in a rabbit model of restenosis.

Cardiovascular research 20010301

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Clinical cancer research : an official journal of the American Association for Cancer Research 20010301

DNA interstrand crosslink formation by mechlorethamine at a cytosine-cytosine mismatch pair: kinetics and sequence dependence.

Archives of biochemistry and biophysics 20010215

The influence of mechlorethamine on the activity of ecto-ATPase of rat lymphocytes.

Annales pharmaceutiques francaises 20010201

Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature.

Cutis 20010201

Current treatment of Cutaneous T-Cell Lymphoma.

Dermatology online journal 20010201

Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.

European journal of haematology 20010101

Hodgkin's disease: clinical presentation and treatment.

Cancer treatment and research 20010101

Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.

Journal of periodontology 20010101

Treatment of advanced stage Hodgkin's disease.

Oncology 20010101

Treatment of VX2 carcinoma implanted in the liver with arterial and intraperitoneal administration of oily anticancer agents.

Cancer chemotherapy and pharmacology 20010101

[Gene protective effect of the short-chain derivative of Vitamin E under the action of alkylating compounds].

TSitologiia i genetika 20010101

[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].

La Clinica terapeutica 20010101

Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.

Cancer gene therapy 20000501

Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns.

Burns : journal of the International Society for Burn Injuries 19980301

Histopathologic and immunohistochemical features in human skin after exposure to nitrogen and sulfur mustard.

The American Journal of dermatopathology 19980201

Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.

Angiology 19971201

N-acetylcysteine protects lymphocytes from nitrogen mustard-induced apoptosis.

Biochemical pharmacology 19960503

Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.

Human gene therapy 19960501

Effect of some anticancer drugs and combined chemotherapy on renal toxicity.

Biological signals 19960101

Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.

The Journal of clinical investigation 19951201

Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts.

Cancer research 19940815

Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents.

Cancer chemotherapy and pharmacology 19940101

Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.

Leukemia & lymphoma 19931001

Granulocyte colony stimulating factor (G-CSF) for mustard-induced bone marrow suppression.

Military medicine 19930701

G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

The Journal of biological chemistry 19930415

Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.

Blood reviews 19920901

[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].

Presse medicale (Paris, France : 1983) 19891125

[Secondary leukemia (AML) with TcR beta rearrangement].

[Rinsho ketsueki] The Japanese journal of clinical hematology 19890801

Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease.

Cancer 19860315

MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19850901

BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.

Annals of internal medicine 19841001

Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.

Annals of internal medicine 19841001

Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation.

Annals of internal medicine 19820801

Central nervous system disturbances after combined administration of procarbazine and mechlorethamine.

Cancer treatment reports 19771201

Failure to induce tolerance to mechlorethamine hydrochloride.

Archives of dermatology 19771001

[Increased hematological toxicity of antineoplastic drugs with simultaneous androgenotherapy (author's transl)].

La Nouvelle presse medicale 19770917

Combination chemotherapy-radiotherapy for stage 3 Hodgkin's disease. An acute leukemia group B study.

Archives of internal medicine 19730301

Combination chemotherapy of Hodgkin's disease in private practice.

JAMA 19720717

Severe cerebral toxicity after intravenous nitrogen mustard therapy.

Cancer 19720201

Hemorrhagic encephalopathy induced by cyclophosphamide (NSC-26271) in suckling rats.

Cancer chemotherapy reports 19700801

Successful therapy of trimethadione nephrosis with prednisone and cyclophosphamide. Report of a case.

The Journal of pediatrics 19670801